Santa Ana, CA-based Robinson Pharma announced that its glucosamine formulations received approval letters from the U.S. Pharmacopeia.

Premium Ingredients International changed its name to Prinova. The firm, based in Carol Stream, IL, will not change ownership.

Lonza, headquartered in Basel, Switzerland, announced its International Patent Application WO 2011/038898 was published by the World Intellectual Property Organization for larch arabinogalactan. This ingredient is main component of its ResistAid immune-health ingredient.

Sunbio Corp. was issued a product license for the use of EstroG-100 in Canada by Health Canada and the Natural Health Products Directorate.

A study on mice published in Frontiers in Nutrigenomics showed that omega-3s delivered in phospholipid form (in krill oil) benefited gene regulation in the liver better than omegas delivered in triglyceride form (in fish oil).eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). “Krill oil downregulated the activity of pathways involved in hepatic glucose production as well as lipid and cholesterol synthesis. The data also suggested that krill oil-supplementation increases the activity of the mitochondrial respiratory chain,” according to Aker BioMarine ASA of Oslo, Norway. The lead author was affiliated with Aker.

In other news, Aker BioMarine and Schiff Nutrition expanded their supply agreement through June 2016 for Aker’s krill oil. 

The American Herbal Products Association of Silver Spring, MD, released the revised AHPA NDI Database and the AHPA Notifications Submissions Package “to assist companies that intend to sell an NDI or a dietary supplement that contains an NDI.” Information is available at

New York, NY-based Kyowa Hakko Bio Co., Ltd., issued a 10% price increase on all new business for all company products because of rising corn and fuel prices worldwide. 

Published in WholeFoods Magazine, August 2011